GSK CFO and new CEO Luke outline R&D, launches and simplification focus
GSK’s CFO Julie Brown and the company’s new CEO Luke discuss early priorities since the CEO transition at the start of the year. The focus is on accelerating R&D, fueling product launches, and simplifying the business. The CEO describes setting up a Strategic Portfolio Review Group that meets every two weeks with program leaders.